A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF)

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

July 14, 2022

Study Completion Date

July 14, 2022

Conditions
Cystic Fibrosis
Interventions
DRUG

ELX/TEZ/IVA

Fixed dose combination (FDC) tablets for oral administration.

DRUG

IVA

Tablets for oral administration.

Trial Locations (41)

Unknown

Royal Adelaide Hospital, Adelaide

The Prince Charles Hospital, Chermside

Alfred Hospital, Melbourne

Telethon Kids Institute, Nedlands

The Royal Children's Hospital, Parkville, VIC

Sydney Children's Hospital, Randwick

Mater Adult Hospital, South Brisbane

Queensland Children's Hospital, South Brisbane

Westmead Hospital, Westmead

Cliniques Universitaires de Bruxelles Hopital Erasme, Brussels

Universitair Ziekenhuis Gent, Ghent

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven

Klinika Nemoci Plicnich a Tuberkulozy, Brno

Fakultni nemocnice v Motole, Prague

Centre Hospitalier Intercommunal Creteil, Créteil

CHRU de Lille - Hopital Albert Calmette, Lille

CHU Marseille - Hopital Nord, Marseille

Hopital Arnaud de Villeneuve, Montpellier

Centre Hospitalier Universitaire De Nantes - G. R. Laennec, Nantes

Centre Hospitalier Universitaire (CHU) de Nice - Hopital Pasteur, Nice

Centre Hospitalier Lyon Sud, Pierre-Bénite

CHU de Rouen - Hopital Charles Nicolle, Rouen Cedex, Seine Maritime

Hopitaux Universitaires de Strasbourg, Strasbourg

Hopital Foch (Suresnes), Hopital Foch, Adultes, Suresnes

Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona

IRCCS Istituto Giannina Gaslini-Ospedale Pediatrico, Genova

Azienda Ospedaliera Universitaria Policlinico G. Martino, Messina

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

Azienda Ospedaliero Universitaria Federico II Napoli, Naples

Azienda Ospedaliera di Verona - Ospedale Civile Maggiore, Verona

Academisch Medisch Centrum (Academic Medical Centre), Amsterdam

University Medical Center, Utrecht, Department of Pulmonology and Tuberculosis, Heidelberglaan

Erasmus Medical Center, Rotterdam

HagaZiekenhuis van den Haag, The Hague

Hospital Saint Joan de Deu, Barcelona

Hospital Universitari Vall d Hebron, Barcelona

Hospital Universitari Vall d´Hebron Servicio de Broncoscopia, Barcelona

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario Ramon y Cajal, Madrid

Hospital Virgen de la Arrixaca, Murcia

Hospital Universitario Virgen del Rocio, Seville

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT04599465 - A Study to Assess the Effect of ELX/TEZ/IVA on Glucose Tolerance in Participants With Cystic Fibrosis (CF) | Biotech Hunter | Biotech Hunter